S. Emre et al., Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant, MT SINAI J, 66(5-6), 1999, pp. 310-313
In liver transplant (LTx) recipients, gut-associated bacterial and fungal o
rganisms produce significant postoperative morbidity and mortality. We soug
ht to assess the role of selective digestive decontamination (SDD) in preve
nting postoperative infections in a large single-center cohort of liver rec
ipients transplanted under two non-simultaneous protocols. In 212 consecuti
ve patients transplanted between 1/1/91 and 7/31/92, SDD (gentamicin 80 mg,
polymyxin B 100 mg, nystatin suspension 10 mt) was employed, starting afte
r induction of anesthesia and continued until POD 21 (SDD Group). In 157 co
nsecutive patients transplanted between 1/1/93 and 12/31/93, SDD was not us
ed (non-SDD Group). Both groups received IV vancomycin and cefotaxime proph
ylaxis. All culture-positive infections within the first 30 days post-LTx w
ere recorded and classified as bacterial or fungal. Infection-related morta
lity (patients who died of infectious complications without any technical c
omplication) was recorded. Groups did not differ in patient demographics, U
nited Network for Organ Sharing (UNOS) status, use of veno-venous bypass, t
otal/warm ischemia, or length of ICU stay. Infections developed in fewer SD
D patients (56/212; 26%) than non-SDD patients (69/157; 44%) (p<0.001). The
incidence of gram-negative infection was less in the SDD group (11% vs. 26
%, p<0.001) as was gram-positive infection (16% vs. 26%, p<0.001). Among pa
tients who developed infection, there was no difference between groups in i
nfections per patient. Primary graft non-function (PNF) developed in 20 SDD
patients (7/20 had infections) and 8 non-SDD patients (6/8 had infections)
(p=0.06). There were no differences in incidence of fungal infections or o
f infection-related mortality between groups. In the SDD group, there were
fewer abdominal (p<0.001), lung (p<0.001), wound (p<0.01), and urinary trac
t infections (p<0.05).
Conclusion: Use of SDD in liver recipients early after transplant was assoc
iated with significantly fewer infections in the early postoperative period
.